Penn Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-87,224
Closed -$434K 206
2022
Q2
$434K Buy
+87,224
New +$457K 0.05% 167

Other funds holding CELL

Penn Capital Management's CELL Position: Q3 2022 in Review

Penn Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2022, closing a stake of 87,224 shares — an estimated $434K sold.

Penn Capital Management first reported a position in CELL in Q2 2022 and held it in 1 quarter. The position peaked at $434K in Q2 2022. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.

  • Penn Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Penn Capital Management sold 87,224 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $434K.
  • Penn Capital Management first reported a position in PhenomeX Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Penn Capital Management's PhenomeX Inc. Common Stock position peaked at $434K in Q2 2022.
  • 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.

Based on Penn Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.